By Etop Ekanem

In line with the need to collaborate with stakeholders in the pharmaceutical sector to boost the treatment of Gastro-Oesophageal Reflux Disease, GERD, Gaviscon has partnered with a major stakeholder, Society for Gastroenterology and Hepatology in Nigeria, SOGHIN, to host the eight Scientific Conference and Annual General Meeting of the association in Ilorin, Kwara State.

The conference, tagged Infectious Disease and Gastroenterology Practice in Nigeria’ featured expositions by a reputable international experts on the treatment of Reflux Disease.

Speaking on behalf of RB Nigeria Limited at the conference, a Consultant Gastroenterologist at the Aminu Kano Teaching Hospital, Dr. Samaila Adamu, said: “Gaviscon contains Alginates which is very essential in the treatment of people with Gastro-Oesophageal Reflux Disease, commonly known as heartburn.

Consultant Gastroenterologist and Director, Medical Education at Princess Diana of Wales Hospital, United Kingdom, Dr. Asif Naqvi, said the use of Alginate, which is present in Gaviscon, provides the simple solution Reflux Disease.